SCPH scPharmaceuticals
- 4.510
- +0.310+7.38%
- 4.510
- 0.0000.00%
scPharmaceuticals News
ScPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
Craig-Hallum Releases a Buy Rating on ScPharmaceuticals (SCPH)
Express News | ScPharmaceuticals Inc - FDA Has Assigned a Prescription Drug User Fee Act (Pdufa) Target Action Date of March 6, 2025
Express News | ScPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (Snda) Seeking to Expand Furoscix Indication to Include Chronic Kidney Disease
When Will ScPharmaceuticals Inc. (NASDAQ:SCPH) Breakeven?
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
These 2 'Strong Buy' Penny Stocks Are Poised for a Massive Rally, Say Analysts
ScPharmaceuticals to Present at the Jefferies Global Healthcare Conference
Analysts Have Conflicting Sentiments on These Healthcare Companies: ScPharmaceuticals (SCPH), Andlauer Healthcare Group (OtherANDHF) and Roche Holding AG (OtherRHHVF)
Furoscix Growth Prospects Anchor Buy Rating for ScPharmaceuticals
Analysts Are Bullish on These Healthcare Stocks: ScPharmaceuticals (SCPH), Optinose (OPTN)
Express News | HC Wainwright & Co. Reiterates Buy on ScPharmaceuticals, Maintains $18 Price Target
ScPharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Alcon (ALC), ScPharmaceuticals (SCPH) and Ascendis Pharma (ASND)
Buy Rating Affirmed for ScPharmaceuticals Amid Furoscix Success and Market Expansion
scPharmaceuticals | 10-Q: Q1 2024 Earnings Report
Express News | ScPharmaceuticals Q1 2024 GAAP EPS $(0.36) Beats $(0.44) Estimate, Sales $6.10M Beat $5.98M Estimate
ScPharmaceuticals: Anticipate Gross To Net Discount Will Increase, May Approach 30% to 35% by the End of This Yr >SCPH
Express News | ScPharmaceuticals Q1 Net Income USD -14.108 Million Vs. Ibes Estimate USD -17.4 Million
Express News | ScPharmaceuticals Q1 Operating Expenses USD 21.958 Million
Analysis
Price Target
No Data
